Anil Kumar, PharmD, a long-term professor who previously chaired the pharmacy school’s division of pharmacology, was let go after “a rigorous process” and recommendation by a 10-member faculty committee.
The university declined to discuss why Dr. Kumar was under review, citing privacy laws that prevent disclosure of personnel matters.
“When issues are reported with members of our faculty, we investigate and take appropriate actions as dictated by UMKC policy and the collected rules and regulations of the University of Missouri System,” University of Missouri-Kansas City Chancellor Mauli Agrawal told the Star.
His outster follows that of former pharmacy professor Asim Mitra, PhD, who was let go earlier this year.
Dr. Mitra, accused of exploiting graduate students in his lab, was sued by the university for allegedly stealing and selling student research to a drugmaker and defrauding the university of millions of dollars. He was immediately suspended by the university and left in March.
Read the full report here.
More articles on pharmacy:
FDA approves AbbVie’s $59K rheumatoid arthritis drug
Teva launches generic version of EpiPen for kids
American Regent boosted price of essential hospital product by 1,300%
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.